Trial Profile
Phase I single-dose trial of CK-2017357 in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Dec 2010
Price :
$35
*
At a glance
- Drugs Tirasemtiv (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- Sponsors Cytokinetics
- 13 Dec 2010 Results presented earlier in the year, according to a Cytokinetics media release
- 27 Jul 2010 Results presented at the XII International Congress on Neuromuscular Diseases, according to a Cytokinetics media release.
- 14 Jul 2010 Results will be presented at the XII International Congress on Neuromuscular Diseases, according to a Cytokinetics media release.